SELECTION OF POTENTIAL MICRORNA GROUPS FOR GASTRIC CANCER DIAGNOSIS FROM EXISTING DATABASES

Bình Mai Thanh, Hoàn Nghiêm Xuân, Giang Đào Phương, Hạ Nguyễn Nhật

Main Article Content

Abstract

Background: Gastric cancer (GC) ranks as the 4th most common cancer in terms of incidence and the 3rd leading cause of cancer-related mortality in Vietnam. MicroRNAs (miRNAs) are involved in various cellular processes, including proliferation, differentiation, and apoptosis, and play a critical role in the pathogenesis of GC. Due to their high blood stability, non-invasive diagnosis of GC using circulating miRNAs is a promising approach. Methods: miRNA nomenclature, sequence annotation, and target information were retrieved from available database platforms such as miRBase, mirTarbase, miRCancer, and KEGG. Using bioinformatics tools TargetScan and miRDB, collected miRNA databases were analyzed to cluster and predict miRNAs closely associated with GC. Results: A total of 449 miRNAs were extracted from miRBase, mirTarbase, and miRCancer, while 302 miRNAs related to GC were obtained from the KEGG database. After analyzing the two datasets, eight miRNAs (including hsa-miR-144-3p, hsa-miR-424-5p, hsa-miR-34a-5p, hsa-let-7f-5p, hsa-7a-5p, hsa-miR-421, hsa-miR-196b-5p, and hsa-miR-193a-3p) passed the selection analysis in TargetScan and a CWCS score > -0.4 in the miRDB bioinformatics tool, indicating a strong association with GC. Conclusion: Following analysis with TargetScan and miRBase, several potential miRNAs were identified that could be utilized for designing studies to evaluate their diagnostic value in supporting GC diagnosis.

Article Details

References

1. Moore, A.C., J.S. Winkjer, T.T. Tseng, Bioinformatics Resources for MicroRNA Discovery. Biomark Insights, 2015. 10(Suppl 4): p. 53-8.
2. Chou, N.H., et al., MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1. Anticancer Res, 2018. 38(6): p. 3309-3318.
3. Gorur, A., et al., Determination of plasma microRNA for early detection of gastric cancer. Mol Biol Rep, 2013. 40(3): p. 2091-6.
4. Jiang, Z., et al., Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol, 2010. 45(1): p. 17-23.
5. Li, B., et al., MicroRNA-144-3p suppresses gastric cancer progression by inhibiting epithelial-to-mesenchymal transition through targeting PBX3. Biochem Biophys Res Commun, 2017. 484(2): p. 241-247.
6. Liu, W.J., et al., Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous disease. Tumour Biol, 2015. 36(5): p. 3337-43.
7. Ogata, H., et al., KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res, 1999. 27(1): p. 29-34.
8. Wei, B., et al., MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET. Mol Med Rep, 2015. 12(4): p. 5255-61.